Seebri Neohaler

Active Ingredient(s): Glycopyrrolate
FDA Approved: * October 29, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Seebri Neohaler Overview

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. It is available in by mouth, intravenous, topical, and inhalated forms. It is a synthetic quaternary ammonium. It was developed by Sosei and licensed to Novartis in 2005. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was ...

Read more Seebri Neohaler Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glycopyrrolate

Recent Seebri Neohaler Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Seebri Neohaler: (2 results)

Sorted by National Drug Code

• 0078-0662 Seebri Neohaler 15.6 ug/1 Respiratory (Inhalation) Capsule by Novartis Pharmaceuticals Corporation
• 63402-815 Seebri Neohaler 15.6 ug/1 Respiratory (Inhalation) Capsule by Sunovion Pharmacueticals Inc.

Other drugs which contain Glycopyrrolate or a similar ingredient: (10 results)

• CUVPOSA Glycopyrrolate
• GLYCOPYRROLATE 12 discussions
• GLYRX-PF Glycopyrrolate
• LONHALA MAGNAIR KIT Glycopyrrolate
• ROBINUL Glycopyrrolate1 discussion
• ROBINUL INJECTABLE Glycopyrrolate
• BEVESPI AEROSPHERE Glycopyrrolate + Formoterol Fumarate1 discussion
• GLYCOPYRROLATE + FORMOTEROL FUMARATE
• INDACATEROL + GLYCOPYRROLATE
• UTIBRON NEOHALER Indacaterol + Glycopyrrolate

Related Seebri Neohaler Topics: